Clinical Report: Analysis of Antibiotic Use and Resistance Trends in Neonates
Overview
This study evaluates antibiotic consumption and resistance patterns among neonates over a decade. Findings indicate high rates of multidrug resistance, particularly with aminoglycosides and penicillin, emphasizing the need for improved antimicrobial stewardship.
Background
Antimicrobial resistance (AMR) is a critical global health issue, particularly in vulnerable populations such as neonates. The high incidence of neonatal sepsis and the widespread use of antibiotics in neonatal intensive care units contribute to rising resistance rates. Understanding antibiotic utilization and resistance patterns is essential for developing effective treatment protocols and stewardship programs.
Data Highlights
Antibiotic Class
DDD
DOT
Aminoglycosides
3089.449
2915
Penicillin
3003.22
2218
Cephalosporins
1164.88
744
Key Findings
Top prescribed antibiotics include aminoglycosides, penicillin, and cephalosporins.
Coagulase-negative staphylococci, Klebsiella pneumoniae, and Staphylococcus aureus are the most prevalent microorganisms.
16 out of 21 identified isolates were multidrug resistant (MDR).
Gentamicin and clindamycin showed high resistance rates among commonly used antibiotics.
Significant correlation exists between antibiotic consumption and resistance patterns in neonates.
Clinical Implications
The high rates of antibiotic resistance among commonly used antibiotics in neonates highlight the urgent need for antimicrobial stewardship programs. Clinicians should consider resistance patterns when prescribing antibiotics to minimize the risk of treatment failure and adverse outcomes.
Conclusion
The findings underscore the critical need for enhanced monitoring and stewardship of antibiotic use in neonatal care to combat rising resistance rates and safeguard neonatal health.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
